Kinexum

Name

Kinexum

Legal name

Kinexum

Website

https://kinexum.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

Kinexum is a private, founder-led regulatory consulting firm founded in 2003 that provides expert services across FDA, EMA, and MHRA pathways to pharmaceutical, biotechnology, and medical device companies globally, drawing on a network of 70+ subject-matter experts.

Ownership category

akta.pro rank

Product category

Regulatory Consulting Services

NAICS

Management, Scientific, and Technical Consulting Services (5416), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Regulatory Strategy & Global Submissions (IND/CTA/NDA/BLA/MAA) (HLAGAKAA)

akta.pro secondary industries

Regulatory Operations & Publishing (eCTD, RIM, Submission Management) (HLAGAKAC), CMC Regulatory Affairs (Modules 2/3, Variations, Post-Approval CMC) (HLAGAKAB), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)

Keywords

• Regulatory consulting services
• FDA submissions support
• Pharmaceutical compliance consulting
• Medical device regulatory strategy
• Life sciences due diligence

Headquarters

HQ city

Harpers Ferry

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Regulatory Consulting Services: Professional consulting services for regulatory strategy, compliance, due diligence, FDA designations, nonclinical work, CMC, quality assurance, and rescue/litigation support for life sciences companies developing pharmaceutical, biologic, and medical device products.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

Core offering

Kinexum provides regulatory consulting services for life sciences companies developing pharmaceutical, biologic, and medical device products. The firm delivers expertise across eight core practice areas—regulatory strategy and compliance, corporate strategy, due diligence, FDA special designations, nonclinical, CMC, quality assurance and control, and rescue/litigation—leveraging a network of more than 70 subject matter experts with experience at FDA, EMA, and MHRA.

Product overview

Kinexum is a regulatory consulting services firm that operates as a single unified service offering rather than a platform-plus-modules architecture. The company provides expert regulatory consulting services across eight core consulting practice areas: Regulatory Strategy and Compliance, Corporate Strategy, Due Diligence, Special FDA Designations, Nonclinical, CMC (Chemistry, Manufacturing, and Controls), Quality Assurance and Control, and Rescue and Litigation. Additionally, Kinexum operates the Kitalys Institute as a not-for-profit initiative focused on healthspan and longevity research, and produces educational content through the Targeting Healthy Longevity webinar series, the annual Wow or Yeow?! FDA outlook webinars, and the Kinexions newsletter. The consulting services are delivered through teams of subject matter experts, many with former experience at regulatory agencies like FDA, EMA, and MHRA.

Differentiator

Problem solved

Functional benefit

Brands

• Kitalys Institute: Not-for-profit institute founded by Kinexum to preserve health, protect against disease, and prolong healthspan. Focuses on metabesity - chronic diseases associated with aging such as diabetes, obesity, and cancer.

Products and services

• Regulatory Strategy and Compliance Consulting Provides regulatory strategy including product development, approval, and post-market compliance with FDA (US), MHRA (UK), and EMA (EU) guidance. Services include regulatory pathway analysis, submission preparation, label negotiations, and FDA special designations.
• Corporate Strategy Consulting Helps clients with corporate strategy questions including competitive prospects, market prioritization, combination product strategies, target indication selection, program prioritization, portfolio management, and fundraising support.
• Due Diligence Consulting Provides 'red team' assessments for emerging companies and experienced clients seeking independent review. Offers risk mitigation strategies, identifies opportunities to increase value, and evaluates regulatory dossiers including quality management systems.
• Special FDA Designations Consulting Assists companies in designing clinical trials and preparing applications for FDA designations including Breakthrough, Fast Track, Priority Review, Accelerated Approval, and Orphan Drug designations.
• Nonclinical Consulting Provides nonclinical consulting services for sponsors moving into the clinic, including review of nonclinical dossier (in vitro and in vivo studies), toxicology and pharmacology study design, and nonclinical module preparation for regulatory submissions.
• Chemistry, Manufacturing, and Controls (CMC) Consulting Provides CMC consulting services to help optimize formulation, synthesis, manufacturing, controls, and processes required to make products and supply them to clinical sites. Includes clinical supply planning, CDMO selection, and regulatory submission preparation.
• Quality Assurance and Control Consulting Ensures conformance to Good Laboratory Practice (GLP), Good Clinical Practice (GCP), and Good Manufacturing Practice (GMP). Services include SOP creation, in-person and virtual audits, regulatory inspection preparation, and third-party vendor assessment.
• Rescue and Litigation Consulting Offers rescue and salvage services for compliance challenges, including root cause identification, corrective action plans, FDA correspondence remediation, and expert witness services for litigation matters.

Quantifiable outcome

• Supported over 500 companies across the globe
• +1 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Healthspan Action Coalition (HSAC)coreStrategic or Co-development PartnerThe Kitalys Institute (founded by Kinexum) collaborates with the Healthspan Action Coalition on the THRIVE Act initiative, which advocates for policies accelerating development of healthspan-supporting products. This partnership focuses on legislative advocacy for expedited regulatory pathways.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Parexel International: Large CRO offering regulatory consulting, submission management, and clinical development services. Competes with Kinexum for biotech regulatory engagements and due diligence work.
• IQVIA (Regulatory & Quality): Global CRO with a deep regulatory affairs and quality assurance practice serving large pharma and emerging biotech. Broader portfolio than Kinexum but competes for the same regulatory strategy and submissions work.
• Charles River Laboratories: Global CRO/CDMO with regulatory affairs and consulting services spanning drugs, biologics, and devices. Overlaps with Kinexum's CMC, nonclinical, and submission-preparation services.

Direct peers

• The Weinberg Group: Regulatory and quality consulting firm for medical devices, combination products, and drugs. Comparable to Kinexum on rescue work, FDA remediation, and QA consulting.
• Camargo Pharmaceutical Services: Specialty regulatory consulting firm focused on 505(b)(2), ANDA, and complex generic and specialty drug pathways. Overlaps with Kinexum on regulatory strategy, CMC, and FDA submission services.
• Greenleaf Health: FDA-focused regulatory consulting firm with deep agency-veteran bench serving pharma, biotech, and medical device clients. Comparable to Kinexum's FDA-special-designations, regulatory strategy, and due diligence offerings.
• ProPharma Group: Regulatory, compliance, and quality consulting firm serving pharma, biotech, and medical device companies. Closely comparable to Kinexum's quality assurance, GxP, and FDA strategy practices.
• Biologics Consulting Group: Boutique regulatory and compliance consulting firm serving biologics, drugs, devices, and combination products. Directly comparable to Kinexum in service portfolio (CMC, nonclinical, QA, FDA strategy) and in the FDA-veteran consultant model.
• NDA Group (NDA Regulatory Sciences): Specialist regulatory affairs consultancy with FDA, EMA, and MHRA expertise across drugs, biologics, devices, and combination products. Closely matches Kinexum's global regulatory strategy, due diligence, and submission services.

Others

• Covington & Burling (FDA Practice): Law firm with premier FDA and life sciences regulatory practice. Overlaps with Kinexum on regulatory strategy, FDA designations, and rescue/litigation matters but operates under an attorney-services model rather than pure consulting.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCtqsMiwNH6D2VeV-vLtqvKQ

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kinexum